1. Home
  2. PCRX vs EE Comparison

PCRX vs EE Comparison

Compare PCRX & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • EE
  • Stock Information
  • Founded
  • PCRX 2006
  • EE 2003
  • Country
  • PCRX United States
  • EE United States
  • Employees
  • PCRX N/A
  • EE N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • EE Oil/Gas Transmission
  • Sector
  • PCRX Health Care
  • EE Utilities
  • Exchange
  • PCRX Nasdaq
  • EE Nasdaq
  • Market Cap
  • PCRX 604.7M
  • EE 588.7M
  • IPO Year
  • PCRX 2011
  • EE 2022
  • Fundamental
  • Price
  • PCRX $22.38
  • EE $31.39
  • Analyst Decision
  • PCRX Buy
  • EE Hold
  • Analyst Count
  • PCRX 10
  • EE 7
  • Target Price
  • PCRX $27.60
  • EE $29.43
  • AVG Volume (30 Days)
  • PCRX 787.3K
  • EE 203.4K
  • Earning Date
  • PCRX 02-27-2025
  • EE 02-26-2025
  • Dividend Yield
  • PCRX N/A
  • EE 0.42%
  • EPS Growth
  • PCRX N/A
  • EE N/A
  • EPS
  • PCRX N/A
  • EE 0.94
  • Revenue
  • PCRX $694,957,000.00
  • EE $816,929,000.00
  • Revenue This Year
  • PCRX $4.83
  • EE N/A
  • Revenue Next Year
  • PCRX $2.16
  • EE $2.41
  • P/E Ratio
  • PCRX N/A
  • EE $34.49
  • Revenue Growth
  • PCRX 4.40
  • EE N/A
  • 52 Week Low
  • PCRX $11.16
  • EE $13.38
  • 52 Week High
  • PCRX $34.01
  • EE $32.99
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 71.48
  • EE 62.77
  • Support Level
  • PCRX $18.18
  • EE $27.38
  • Resistance Level
  • PCRX $22.88
  • EE $32.99
  • Average True Range (ATR)
  • PCRX 1.14
  • EE 1.10
  • MACD
  • PCRX 0.32
  • EE 0.14
  • Stochastic Oscillator
  • PCRX 96.36
  • EE 87.96

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About EE Excelerate Energy Inc.

Excelerate Energy Inc is engaged in flexible LNG solutions, providing integrated services along the LNG value chain. The company offers a full range of flexible regasification services from FSRUs to infrastructure development, to LNG and natural gas supply.

Share on Social Networks: